Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CANCER GENETICS, INC | 200,000 | reported | 22 Feb 2017 | tx 8+802,500 |
| Lantern Pharma Inc. | 70,000 | reported | 15 Jul 2024 | tx 5+323,256−76,628 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jun 2020 | OTHER | Lantern Pharma Inc. | 76,628 | 0.00 USD | deriv |
| 15 Jun 2020 | GRANT_AWARD | Lantern Pharma Inc. | 76,628 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | Lantern Pharma Inc. | 70,000 | 0.00 USD | deriv |
| 06 Aug 2022 | GRANT_AWARD | Lantern Pharma Inc. | 100,000 | 0.00 USD | deriv |
| 15 Jun 2020 | GRANT_AWARD | Lantern Pharma Inc. | 76,628 | — | deriv |
| 22 Feb 2017 | GRANT_AWARD | CANCER GENETICS, INC | 200,000 | 0.00 USD | deriv |
| 17 Mar 2016 | PURCHASE | CANCER GENETICS, INC | 500 | 2.58 USD | |
| 16 Mar 2016 | PURCHASE | CANCER GENETICS, INC | 1,000 | 2.60 USD | |
| 15 Mar 2016 | PURCHASE | CANCER GENETICS, INC | 1,000 | 2.56 USD | |
| 11 Dec 2014 | GRANT_AWARD | CANCER GENETICS, INC | 100,000 | 0.00 USD | |
| 11 Dec 2014 | GRANT_AWARD | CANCER GENETICS, INC | 250,000 | 0.00 USD | deriv |
| 22 May 2014 | GRANT_AWARD | CANCER GENETICS, INC | 50,000 | 0.00 USD | |
| 10 Oct 2013 | GRANT_AWARD | CANCER GENETICS, INC | 200,000 | 0.00 USD | deriv |